← Back to Patent Explorer
US4077407A Expired / Lapsed US ⏱️ 0.0 years remaining

Osmotic devices having composite walls

Assignee: Alza Corp
•
Filing: 1975-11-24
•
Granted: 1978-03-07
•
Expires: 1995-11-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An osmotic device for delivering an active agent is disclosed. The device is comprised of a wall surrounding a compartment and has a passageway through the wall for releasing the agent. The wall is formed of a multiplicity of materials comprising a material permeable to an external fluid and substantially impermeable to agent and at least one additional material selected from a material that imparts stability to the wall, enhances the permeability of the wall to fluids, or aids in forming the wall. The compartment comprises an active agent that exhibits an osmotic pressure gradient against an external fluid, or the agent is mixed with an osmotically effective compound that exhibits an osmotic pressure gradient against the fluid. Agent is released from the device by fluid being imbibed through the wall into the compartment at a rate controlled by the permeability of the wall and the osmotic pressure gradient across the wall, to produce a solution containing agent that is released through the passageway at a controlled and continuous rate over a prolonged period of time.

Inventors

  • 👤 Felix Theeuwes
  • 👤 Atul D. Ayer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 18:58
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034; A61K9/0036; A61K9/0002; A61K9/0004

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 293 words
An osmotic device for dispensing a drug to an animal comprising: (a) a shaped wall that is substantially inert and maintains its physical and chemical integrity during the controlled dispensing of the drug comprising: (1) a semipermeable wall forming material that is permeable to the passage of an external fluid and substantially impermeable to the passage of the drug, said semipermeable material being a polymer of the following formula ##STR4## wherein R 1 , R 2 , and R 3 are selected from the group consisting of hydrogen, alkyl, alkenyl, and acyl and n is greater than 5, and (2) a stabilizing material that imparts inertness and stability to the wall, and which stabilizing material is a different polymer of the following formula: ##STR5## wherein R 5 is a member selected from the group consisting of hydroxyl, alkoxy, hydroxyl-substituted alkoxy, alkylcarbonate, alkylcarbamate, alkylsulfonate, alkylsulfamate, and acyloxy, and n is greater than 5; (b) a compartment formed by the shaped wall and containing the drug, said drug being a member selected from the group consisting of locally and systemically acting drugs; (c) a passageway in the wall communicating with the compartment and the exterior of the device for dispensing the drug from the device; and, (d) wherein in operation when the device is dispensing the drug to the animal, fluid therefrom is continuously imbibed through the wall into the compartment in a tendency towards osmotic equilibrium at a rate determined by the permeability of the wall and the osmotic pressure gradient across the wall, thereby forming a solution containing drug which is dispensed through the passageway at a controlled rate, with the wall substantially maintaining its inertness and integrity in the presence of the drug and solution thereof over a prolonged period of time.
Claim 2
Dependent Claim 293 words
An osmotic device for dispensing a drug to an animal comprising: (a) a shaped wall that is substantially inert and maintains its physical and chemical integrity during the controlled dispensing of the drug comprising: (1) a semipermeable wall forming material that is permeable to the passage of an external fluid and substantially impermeable to the passage of the drug, said semipermeable material being a polymer of the following formula ##STR4## wherein R 1 , R 2 , and R 3 are selected from the group consisting of hydrogen, alkyl, alkenyl, and acyl and n is greater than 5, and (2) a stabilizing material that imparts inertness and stability to the wall, and which stabilizing material is a different polymer of the following formula: ##STR5## wherein R 5 is a member selected from the group consisting of hydroxyl, alkoxy, hydroxyl-substituted alkoxy, alkylcarbonate, alkylcarbamate, alkylsulfonate, alkylsulfamate, and acyloxy, and n is greater than 5; (b) a compartment formed by the shaped wall and containing the drug, said drug being a member selected from the group consisting of locally and systemically acting drugs; (c) a passageway in the wall communicating with the compartment and the exterior of the device for dispensing the drug from the device; and, (d) wherein in operation when the device is dispensing the drug to the animal, fluid therefrom is continuously imbibed through the wall into the compartment in a tendency towards osmotic equilibrium at a rate determined by the permeability of the wall and the osmotic pressure gradient across the wall, thereby forming a solution containing drug which is dispensed through the passageway at a controlled rate, with the wall substantially maintaining its inertness and integrity in the presence of the drug and solution thereof over a prolonged period of time.
Claim 3
Dependent Claim 60 words
The osmotic device for dispensing a drug according to claim 1, wherein the device is sized, shaped and adapted as a dosage form for the administration of locally and systemically acting drugs to the gastro-intestinal tract and the semipermeable wall forming polymeric material has a degree of substitution on its anhydroglucose groups greater than 0 and up to 3 inclusive.
Claim 4
Dependent Claim 56 words
The osmotic device for dispensing a drug according to claim 1, wherein at least one of R 1 , R 2 and R 3 is acyl and the semipermeable wall forming material is a member selected from the group consisting of cellulose acetate, cellulose diacetate, cellulose triacetate, cellulose propionate, cellulose acetate propionate, and cellulose acetate butyrate.
Claim 5
Dependent Claim 86 words
The osmotic device for dispensing a drug according to claim 1, wherein the stabilizer material has a degree of substitution on its anhydroglucose groups of greater than 0 and up to 3 inclusive, and is a different material than the semipermeable wall forming material and which stabilizer material is a member selected from the group consisting of cellulose esters, cellulose ethers, mixed cellulose esters and ethers, cellulose acetate, cellulose diacetate, cellulose triacetate, hydroxyethyl methylcellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxybutyl cellulose, and hydroxybutyl methyl methylcellulose.
Claim 6
Dependent Claim 78 words
The osmotic device for dispensing a drug according to claim 1, wherein the composite wall contains a dispersant that blends the semipermeable and stabilizing materials into the stable wall, said dispersant being a member selected from the group consisting of an amphiphatic, anionic, cationic, nonionic and amphoteric dispersants selected from the group consisting of polyoxyalkylene glycols, esters of polyoxyalkylene glycols, esters of polyhydric alcohols, sulfates esters, sulfated amides, quaternary ammonium salts, alkanolamine fatty acids and tertiary alkyl-ammonium salts.
Claim 7
Dependent Claim 48 words
The osmotic device for dispensing a drug according to claim 1, wherein the shaped wall contains a plasticizer that lowers the temperature of the second-order transition of the wall, is compatible with the materials forming the wall, increases the flexibility of the wall, and is non-toxic to animals.
Claim 8
Dependent Claim 72 words
The osmotic device for dispensing a drug according to claim 1, wherein the shaped wall contains a plasticizer that lowers the temperature of the second-order transition of the wall, is compatible with the materials forming the wall, increases the flexibility of the wall, is non-toxic to animals, and is a member selected from the group consisting of phthalates, phosphates, citrates, adipates, tartrates, sebacates, succinates, glycolates, glycerolates, benzoates, myristates, sulfonamides, and halogenated phenyls.
Claim 9
Dependent Claim 60 words
The osmotic device for dispensing a drug according to claim 1, wherein the shaped wall has a permeability to the external fluid of 10 -5 to 10 -1 cc mil/cm 2 .hr.atm, and it contains a flux enhancer that assists in regulating the permeability of the wall to the passage of external fluid, said flux enhancer being a polyhydric alcohol.
Claim 10
Dependent Claim 74 words
The osmotic device for dispensing a drug according to claim 1, wherein the shaped wall has a permeability to the external fluid of 10 -5 to 10 -1 cc.mil/cm 2 .hr.atm, and it contains a flux enhancer that assists in regulating the permeability of the wall to the passage of external fluid, said flux enhancer being a member selected from the group consisting of aliphatic diols, polyalkylene glycols, poly(α,ω)-alkylenediols, esters of, and mixtures thereof.
Claim 11
Dependent Claim 59 words
The osmotic device for dispensing drug according to claim 5, wherein the shaped wall contains from 0.001 to 50 parts of a flux enhancer that assists in regulating the fluid permeability of the wall and which flux enhancer is a member selected from the group consisting of hydrophilic and hydrophobic polyalkylene glycols, poly(α,ω)-alkylenediols, aliphatic diols and alkylene glycol esters.
Claim 12
Dependent Claim 43 words
The osmotic device for dispensing a drug according to claim 5, wherein the shaped wall contains from 0.001 to 50 parts of a flux enhancer that assists in regulating the fluid permeability of the wall and which flux enhancer is an alkylene glycol.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-03-06 1981-09-05 1982-03-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-03-06 1985-09-05 1986-03-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-03-06 1989-09-05 1990-03-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag